Cholinesterase Inhibitors

retired
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.140
Version
20190328
PublisherAmerican Academy of Neurology StewardDate2019-03-28T01:00:10-04:00Description

Intended to capture cholinesterase inhibitors developed Q2 2019.

Purpose

(Clinical Focus: RxNorm codes for cholinesterase inhibitors),(Data Element Scope: RxNorm codes),(Inclusion Criteria: donepezil, galantamine, rivastigmine),(Exclusion Criteria: N/A)

Expansion
<<>>>
CodeDisplaySystem
314215http://www.nlm.nih.gov/research/umls/rxnorm
1602593http://www.nlm.nih.gov/research/umls/rxnorm
1805426http://www.nlm.nih.gov/research/umls/rxnorm
997229http://www.nlm.nih.gov/research/umls/rxnorm
1100184http://www.nlm.nih.gov/research/umls/rxnorm
226666http://www.nlm.nih.gov/research/umls/rxnorm
330343http://www.nlm.nih.gov/research/umls/rxnorm
483071http://www.nlm.nih.gov/research/umls/rxnorm
998582http://www.nlm.nih.gov/research/umls/rxnorm
602736http://www.nlm.nih.gov/research/umls/rxnorm
860693http://www.nlm.nih.gov/research/umls/rxnorm
367663http://www.nlm.nih.gov/research/umls/rxnorm
860695http://www.nlm.nih.gov/research/umls/rxnorm
583101http://www.nlm.nih.gov/research/umls/rxnorm
1599805http://www.nlm.nih.gov/research/umls/rxnorm
994808http://www.nlm.nih.gov/research/umls/rxnorm
702120http://www.nlm.nih.gov/research/umls/rxnorm
860707http://www.nlm.nih.gov/research/umls/rxnorm
310436http://www.nlm.nih.gov/research/umls/rxnorm
310437http://www.nlm.nih.gov/research/umls/rxnorm